List of countries by antidepressant consumption


This is a list of countries by antidepressant consumption according to data published by the OECD.

OECD list

edit

The source for the data below is the OECD Health Statistics 2018, released by the OECD in June 2018 and updated on 8 November 2018.[1]

The unit of measurement used by the OECD is defined daily dose (DDD), defined as "the assumed average maintenance dose per day for a drug used on its main indication in adults".[2] The sources used by the OECD are primarily national health authorities.[2] Definitions, sources and methodology per country is explained further in a document available on the OECD website.[2] The OECD have not included the United States in these reviews, but if added the country would have the highest or second-highest rate.[3]

Country Defined daily dosage
per 1,000 inhabitants per day
Year Data include drugs
dispensed in hospitals
Data include non-
reimbursed drugs
Data include
OTC drugs
Notes
  Iceland 141.4 2017 Yes Yes Yes
  Australia 106.7 2016 No Yes No
  Portugal 103.6 2017 No Yes[note 1] Yes[note 2]
  United Kingdom 100.1 2016 No No
  Canada 99.6 2017 No No See note[note 3] [note 4]
  Sweden 96.8 2017 Yes Yes Yes[note 5]
  Belgium 79.0 2016 No No No
  Denmark 77.0 2015 Yes Yes Yes
  Spain 75.5 2016 No No No
  New Zealand 72.8 2014 [note 6]
  Finland 67.6 2016 Yes[note 7] Yes Yes
  Austria 60.5 2016 No[note 8] See note[note 9] No
  Slovenia 58.6 2016 No See note[note 10] See note[note 11]
  Norway 57.1 2017 Yes Yes Yes
  Czech Republic 57.1 2016 Yes Yes Yes
  Germany 56.5 2016 No See note[note 12] No
  Luxembourg 52.7 2017 No No No [note 4]
  France 49.8 2009 Yes[note 13] Yes Yes
  Israel 49.2 2017 No No No
  Greece 48.1 2015 No No No [note 6]
  Netherlands 46.1 2016 No No No
  Chile 41.4 2017 Yes Yes
  Turkey 41.0 2016 No Yes See note[note 14]
  Italy 40.3 2017 No No [note 15]
  Slovakia 38.9 2016 Yes Yes Yes
  Hungary 28.8 2017 No No No
  Estonia 28.8 2017 Yes Yes Yes
  South Korea 19.9 2016 Yes Yes Yes
  Latvia 13.3 2016

See also

edit

Notes

edit
  1. ^ Data include both reimbursed and non-reimbursed products.
  2. ^ Yes, but only OTC products sold in pharmacies.
  3. ^ Generally, claims for OTC drugs are not reimbursed, but OTC drugs are not explicitly excluded.
  4. ^ a b Provisional value.
  5. ^ Data include OTC drugs both from pharmacies and from other retailers.
  6. ^ a b Difference in methodology.
  7. ^ Data are based on wholesale of pharmaceuticals.
  8. ^ Drug consumption in hospitals and in hospital ambulances is excluded.
  9. ^ Data cover only drugs reimbursed by the sickness funds within the statutory health insurance.
  10. ^ Data include all medicines with a medical prescription – compulsory health insurance, regardless of the reimbursement.
  11. ^ Only OTC drugs with a medical prescription.
  12. ^ Data contain exclusively the drug consumption debited to the statutory health insurance (i.e. drugs reimbursed by German Statutory Health Insurance).
  13. ^ Data include drug consumption both in hospitals and in pharmacies.
  14. ^ Data include drugs dispensed in pharmacies and non-reimbursed drugs.
  15. ^ Estimated value.

References

edit
  1. ^ "OECD Health Statistics 2018". OECD. 28 June 2018. Retrieved 10 May 2019.
  2. ^ a b c "OECD Health Statistics 2018: Definitions, Sources and Methods". OECD. June 2018. Retrieved 10 May 2019.
  3. ^ Gould, S.; L.F. Friedman (4 February 2016). "Something startling is going on with antidepressant use around the world". Business Insider. Retrieved 18 July 2020.
edit